Neo Ivy Capital Management’s West Pharmaceutical WST Stock Holding History

Neo Ivy Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$805K	Buy	+2,242	New	+$685K	0.19%	173
2025 Q4	–	Sell	-6,820	Closed	-$1.79M	–	544
2025 Q3	$1.79M	Buy	+6,820	New	+$1.66M	0.44%	86
2024 Q3	–	Sell	-8,800	Closed	-$2.9M	–	415
2024 Q2	$2.9M	Buy	+8,800	New	+$3.11M	0.57%	85
2020 Q4	–	Sell	-906	Closed	-$249K	–	605
2020 Q3	$249K	Buy	+906	New	+$240K	0.25%	153

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Neo Ivy Capital Management's WST Position: Q2 2026 in Review

Neo Ivy Capital Management opened a new position in West Pharmaceutical (WST) in Q2 2026: 2,242 shares worth $805K. The stake represents 0.19% of the portfolio and ranks #173 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in WST as recently as Q3 2025.

Neo Ivy Capital Management first reported a position in WST in Q3 2020 and has held it in 4 quarters since. The position peaked at $2.9M in Q2 2024. 833 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Neo Ivy Capital Management held 2,242 shares of West Pharmaceutical worth $805K as of Q2 2026.
West Pharmaceutical was a new Neo Ivy Capital Management position in Q2 2026.
West Pharmaceutical made up 0.19% of Neo Ivy Capital Management's portfolio in Q2 2026, its #173 holding.
Neo Ivy Capital Management first reported a position in West Pharmaceutical in Q3 2020 and has held it in 4 quarters since.
Neo Ivy Capital Management's West Pharmaceutical position peaked at $2.9M in Q2 2024.
833 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.